These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21165562)

  • 1. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
    Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
    Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.
    Chen YJ; Luo J; Yang GY; Yang K; Wen SQ; Zou SQ
    World J Gastroenterol; 2012 Aug; 18(29):3849-61. PubMed ID: 22876037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
    Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells.
    Guo N; Chen R; Li Z; Liu Y; Cheng D; Zhou Q; Zhou J; Lin Q
    Acta Biochim Biophys Sin (Shanghai); 2011 May; 43(5):354-61. PubMed ID: 21450690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
    Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma.
    Chen Y; Luo J; Tian R; Sun H; Zou S
    Dig Dis Sci; 2011 Jun; 56(6):1693-701. PubMed ID: 21086164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.
    Lee S; Kim WH; Jung HY; Yang MH; Kang GH
    Am J Pathol; 2002 Sep; 161(3):1015-22. PubMed ID: 12213730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.
    Meng F; Wehbe-Janek H; Henson R; Smith H; Patel T
    Oncogene; 2008 Jan; 27(3):378-86. PubMed ID: 17621267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epigenetic alterations in cholangiocarcinoma.
    Tischoff I; Wittekind C; Tannapfel A
    J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
    Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
    Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.